Drug Trials Saved Lenny, and Will Help Thousands More

Summary: Lenny was given just two years to live after his prostate cancer spread. But his luck changed when he joined a clinical trial at Duke University. He was randomly chosen to get a new drug called olaparib. Doctors later found Lenny had a BRCA gene mutation, which made the drug work perfectly for him. Along with a strict exercise routine, the treatment put his cancer into remission. Now, he gets to watch his grandchild grow up. Because of trials like this, thousands of other patients can now get this life-saving drug.

For more details, see rssapp-news-duke-edu at today.duke.edu/2025/03/drug-trials-saved-lenny-and-will-help-thousands-more (opens in new tab)